Search - tctmd.com

Displaying 101 - 120 of 535

Sort: Relevancy | Date

Presentation NY Valves 2024

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Presenter: Jonathan Michel

June 06, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

Presenter: UTTAM SINGH

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

Presentation NY Valves 2024

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Presenter: Hasan Jilaihawi

June 06, 2024

Presentation NY Valves 2024

Real Dilemma: Precious Pregnancy With Severe Aortic Stenosis, Moderate Severe Aortic Regurgitation

Presenter: Rajneesh Kapoor

June 06, 2024

Presentation NY Valves 2024

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

Presenter: Simon Lam

June 06, 2024

Presentation NY Valves 2024

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

Presenter: Riya Murugesan

June 06, 2024

Presentation NY Valves 2024

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Presenter: Arianna Favela

June 06, 2024

Presentation NY Valves 2024

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Presenter: Torsten P. Vahl

June 05, 2024

Presentation NY Valves 2024

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Presenter: Raj Makkar

June 05, 2024

Presentation NY Valves 2024

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

Presenter: Vinod H. Thourani

June 05, 2024

Presentation NY Valves 2024

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Presenter: Santiago Garcia

June 05, 2024

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

Advertisement

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

JenaValve Following Previous Ross Procedure

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Real Dilemma: Precious Pregnancy With Severe Aortic Stenosis, Moderate Severe Aortic Regurgitation

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content